Overview Rating

Speculative

Technicals Analysis

0100

Financials Analysis

0100

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Kiniksa Pharmaceuticals (KNSA) operate in?

Kiniksa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Kiniksa Pharmaceuticals Stock (NASDAQ: KNSA) stock price, news, charts, stock research, profile.

Open	$21.35
Close	$21.61
Volume / Avg.	383.56K / 394.70K
Day Range	21.22 - 21.86
52 Wk Range	13.91 - 22.12
Market Cap	$1.54B
P/E Ratio	166.15
Dividend Yield	-
Exchange	NASDAQ
RSI	72
Short Interest	14.64%
Days to Cover	7.19

Recent News

Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Longboard Pharmaceuticals, Inc.

Avi Kapoor

Crude Oil Up 1%; Verizon Earnings Beat Views

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Tuesday. The Dow traded up 0.28% to 35,510.96 while the NASDAQ rose 0.91% to 14,187.05. The S&P 500, also rose, gaining, 0.48% to 4,576.60.

Lisa Levin

Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers Aurora Acquisition Corp. (NASDAQ: AURC) shares jumped 192% to $30.54.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Kiniksa Pharmaceuticals International Plc.

Sector

Health Care

Industry

Biotechnology

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on d...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Kiniksa Pharmaceuticals (KNSA) stock?

You can purchase shares of Kiniksa Pharmaceuticals (NASDAQ:KNSA) through any online brokerage.

View our list of the best stock brokerages

Who are Kiniksa Pharmaceuticals (KNSA) competitors?

Other companies in Kiniksa Pharmaceuticals’s space includes: 4D Molecular Therapeutics (NASDAQ:FDMT), Immatics (NASDAQ:IMTX), Arcutis Biotherapeutics (NASDAQ:ARQT), Prothena Corp (NASDAQ:PRTA) and Day One Biopharmaceutical (NASDAQ:DAWN).

What is the target price for Kiniksa Pharmaceuticals (KNSA) stock?

There is no analysis for Kiniksa Pharmaceuticals.

What is the forecast for Kiniksa Pharmaceuticals (KNSA) stock?

Kiniksa Pharmaceuticals has a consensus price target of $30.83.

Current stock price for Kiniksa Pharmaceuticals (KNSA)?

The stock price for Kiniksa Pharmaceuticals (NASDAQ: KNSA) is $21.61 last updated July 15, 2024 at 4:00 PM EDT.

Does Kiniksa Pharmaceuticals (KNSA) pay a dividend?

There are no upcoming dividends for Kiniksa Pharmaceuticals.

When is Kiniksa Pharmaceuticals (NASDAQ:KNSA) reporting earnings?

Kiniksa Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, July 30, 2024.

Is Kiniksa Pharmaceuticals (KNSA) going to split?

There is no upcoming split for Kiniksa Pharmaceuticals.

What sector and industry does Kiniksa Pharmaceuticals (KNSA) operate in?

Kiniksa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Kiniksa Pharmaceuticals

Kiniksa Pharmaceuticals (KNSA) Forecast